DETERMINANTS OF PARTICIPATION SURVIVORS COVID-19 AMONG ≥45 YEARS OLD TO COVID-19 THIRD DOSE VACCINATION DOI Creative Commons
Putri Djamilah Wahidah, Hartati Eko Wardani, Lucky Radita Alma

и другие.

Jurnal Berkala Epidemiologi, Год журнала: 2024, Номер 12(2), С. 192 - 202

Опубликована: Май 30, 2024

Background: Booster vaccinations are a way to keep the body protected against COVID-19. Mojolangu Health Center is one of densely populated areas which part Lowokwaru sub-district and borders Belimbing sub-district; two sub-districts ranked 2nd 1st with highest CFR (Case Fatality Rate) in Malang City. Therefore, examining public perceptions vaccination evaluate immunization programs raise performance goals essential. Purpose: To determine relationship between Belief Model components (perceived susceptibility, severity, benefits, barrier, cues action) participation COVID-19 booster survivors aged ≥45 years. Conducted from April November 2022, this research was located working area (Mojolangu, Tunjungsekar, Tunggulwulung, Tasikmadu village). Methods: This quantitative used case-control design study. sample comprised 82 people, selected using purposive sampling technique 1:1 ratio for case control. Data analysis done Chi-Square test Binary Logistics Regression tests. Results: The respondents were dominated by middle age group (45-59 years), primarily entrepreneurs monthly income more than IDR 3.5 million domiciled village. perceived benefits variable showed p=0.04 (aOR=2.67; 95% CI=1.03-6.91) barriers p=0.01 (aOR=3.60; CI=1.39-9.28), while vulnerability p=1.00 (cOR=1.00; CI= 0.32 – 3.16), perception act p= 0.18 (cOR= 1.82; 0.75 - 4.40). Conclusion: Factors related barriers.

Язык: Английский

COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis DOI Creative Commons
Shaimaa Abdelaziz Abdelmoneim, Malik Sallam, Dina Mohamed Hafez

и другие.

Tropical Medicine and Infectious Disease, Год журнала: 2022, Номер 7(10), С. 298 - 298

Опубликована: Окт. 13, 2022

The World Health Organization (WHO) recommended coronavirus disease 2019 (COVID-19) booster dose vaccination after completing the primary series for individuals ≥18 years and most-at-risk populations. This study aimed to estimate pooled proportion of COVID-19 vaccine uptake intention get among general populations healthcare workers (HCWs). We searched PsycINFO, Scopus, EBSCO, MEDLINE Central/PubMed, ProQuest, SciELO, SAGE, Web Science, Google Scholar, ScienceDirect according PRISMA guidelines. From a total 1079 screened records, 50 studies were extracted. Meta-analysis was conducted using 48 high-quality Newcastle-Ottawa Scale quality assessment tool. Using included studies, acceptance 198,831 subjects 81% (95% confidence interval (CI): 75–85%, I2 = 100%). actual in eight involving 12,995 31% CI: 19–46%, 100%), while have 79% 72–85%, vaccines HCWs 66% 58–74%), 99%). Meta-regression revealed that previous infection associated with lower dose. Conversely, significantly higher level uptake. WHO region Americas, which did not include any vaccination, 77% 66–85%, Western Pacific 89% 84–92%, 100), followed by European region: 86% 81–90%, 99%), Eastern Mediterranean 59% 46–71%, Southeast Asian 52% 43–61%, 95). Having chronic trust effectiveness significant predictors acceptance. global rate is high, but rates vary region. To achieve herd immunity disease, high required. Intensive campaigns programs are still needed around world raise public awareness regarding importance accepting proper control pandemic.

Язык: Английский

Процитировано

64

First COVID-19 Booster Dose in the General Population: A Systematic Review and Meta-Analysis of Willingness and Its Predictors DOI Creative Commons
Petros Galanis, Irène Vraka, Aglaia Katsiroumpa

и другие.

Vaccines, Год журнала: 2022, Номер 10(7), С. 1097 - 1097

Опубликована: Июль 8, 2022

The emergence of breakthrough infections and new highly contagious variants SARS-CoV-2 threaten the immunization in individuals who had completed primary COVID-19 vaccination. This systematic review meta-analysis investigated, for first time, acceptance booster dose its associated factors among fully vaccinated individuals. We followed PRISMA guidelines. searched Scopus, Web Science, Medline, PubMed, ProQuest, CINAHL medrxiv from inception to 21 May 2022. found 14 studies including 104,047 prevalence intend accept a was 79.0%, while unsure 12.6%, that refuse 14.3%. main predictors willingness were older age, flu vaccination previous season, confidence most important reasons decline adverse reactions discomfort experienced after vaccine doses concerns serious doses. Considering burden COVID-19, high rate could be critical controlling pandemic. Our findings are innovative help policymakers design implement specific programs order decrease hesitancy.

Язык: Английский

Процитировано

45

Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic DOI

Rontgene Solante,

Carlos Álvarez, Erlina Burhan

и другие.

Expert Review of Vaccines, Год журнала: 2022, Номер 22(1), С. 1 - 16

Опубликована: Ноя. 4, 2022

COVID-19 vaccines have been highly effective in reducing morbidity and mortality during the pandemic. However, emergence of Omicron variant subvariants as globally dominant strains raised doubts about effectiveness currently available prompted debate potential future vaccination strategies.Using publicly IVAC VIEW-hub platform, we reviewed 52 studies on vaccine (VE) after booster vaccinations. VE were reported for SARS-CoV-2 symptomatic infection, severe disease death stratified by schedule age. In addition, a non-systematic literature review safety was performed to identify single or multi-country investigating adverse event rates at least two vaccines.Booster shots current provide consistently high protection against Omicron-related death. Additionally, this appears be conserved 3 months, with small but significant waning that. The positive risk-benefit ratio these is well established, giving us confidence administer additional doses required. Future strategies will likely include combination schedules based risk profile, overly frequent boosting may neither beneficial nor sustainable general population.

Язык: Английский

Процитировано

41

Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review DOI Creative Commons
Yam B. Limbu, Bruce A. Huhmann

Tropical Medicine and Infectious Disease, Год журнала: 2023, Номер 8(3), С. 159 - 159

Опубликована: Март 5, 2023

As the COVID-19 pandemic continues and transitions to an endemic stage, booster vaccines will play important role in personal public health. However, convincing people take boosters be a key obstacle. This study systematically analyzed research that examined predictors of vaccine hesitancy. A search PubMed, Medline, CINAHL, Web Science, Scopus uncovered 42 eligible studies. Globally, average vaccination hesitancy rate was 30.72%. Thirteen factors influencing emerged from literature: demographics (gender, age, education, income, occupation, employment status, ethnicity, marital status), geographical influences (country, region, residency), adverse events, perceived benefit/efficacy, susceptibility, severity, prior history infection, recommendations, health knowledge information, skepticism/distrust/conspiracy theories, type. Vaccine communication campaigns interventions for COVID should focus on confidence, complacency, convenience.

Язык: Английский

Процитировано

39

How Well the Constructs of Health Belief Model Predict Vaccination Intention: A Systematic Review on COVID-19 Primary Series and Booster Vaccines DOI Creative Commons
Yam B. Limbu, Rajesh K. Gautam

Vaccines, Год журнала: 2023, Номер 11(4), С. 816 - 816

Опубликована: Апрель 7, 2023

This systematic review synthesizes the findings of quantitative studies examining relationships between Health Belief Model (HBM) constructs and COVID-19 vaccination intention. We searched PubMed, Medline, CINAHL, Web Science, Scopus using Preferred Reporting Items for Systematic Reviews Meta-Analyses (PRISMA) guidelines identified 109 eligible studies. The overall intention rate was 68.19%. Perceived benefits, perceived barriers, cues to action were three most frequently demonstrated predictors both primary series booster vaccines. For doses, influence susceptibility slightly increased, but impact severity, self-efficacy, on declined. severity's effect declined sharply from 2020 2022. barriers 2021, it skyrocketed in Conversely, role self-efficacy dipped Susceptibility, dominant Saudi Arabia, had weaker effects USA. Susceptibility severity a lower students, especially North America, health care workers. However, among parents. prevalent modifying variables age, gender, education, income, occupation. results show that HBM is useful predicting vaccine

Язык: Английский

Процитировано

22

A Systematic Review on Sociodemographic, Financial and Psychological Factors Associated with COVID-19 Vaccine Booster Hesitancy among Adult Population DOI Creative Commons

Shruti Ayyalasomayajula,

Aditi Dhawan,

Mohammed Salim Karattuthodi

и другие.

Vaccines, Год журнала: 2023, Номер 11(3), С. 623 - 623

Опубликована: Март 9, 2023

While considerable evidence supports the safety and efficacy of COVID-19 vaccines, a sizable population expresses vaccine hesitancy. As per World Health Organization, hesitancy is one top 10 hazards to global health. Vaccine varies across countries, with India reporting least was higher toward booster doses than previous shots. Therefore, identifying factors determining hesitance (VBH) sine qua non successful vaccination campaign.This systematic review followed Preferred Reporting Items for Systematic Reviews Meta-analysis (PRISMA) 2020 standards. A total 982 articles were pooled from Scopus, PubMed Embase, while 42 that addressed VBH finally included further analysis.We identified responsible divided them into three major groups: sociodemographic, financial, psychological. Hence, 17 stated age be factor hesitancy, most reports suggesting negative correlation between fear poor outcomes. Nine studies found females expressing greater males. Trust deficit in science (n = 14), concerns about 12), lower levels regarding infection 11), worry side effects 8) also reasons Blacks, Democrats, pregnant women showed high Few have income, obesity, social media, living vulnerable members as influencing study 44.1% towards could attributed dominantly low rural origin, previously unvaccinated status, or individuals. However, two other Indian reported lack availability slots, trust government, doses.Many confirmed multifactorial nature VBH, which necessitates multifaceted, individually tailored interventions address all potentially modifiable factors. This chiefly recommends strategizing campaign by evaluating appropriate communication (at both individual community levels) benefits risk losing immunity without them.

Язык: Английский

Процитировано

21

Global disparities in COVID-19 vaccine booster dose (VBD) acceptance and hesitancy: An updated narrative review DOI Creative Commons
Debendra Nath Roy, Nowrin Ferdiousi, Md. Mohabbot Hossen

и другие.

Vaccine X, Год журнала: 2024, Номер 18, С. 100480 - 100480

Опубликована: Март 23, 2024

The global deployment of COVID-19 vaccine booster dose (VBD) has been recognized as a promising therapeutic alliance to provide repeated immunity against the arrival new variants. Despite scientific evidence supports effectiveness periodic doses, reluctance continues thrive. This narrative review aimed examine doses acceptance and summarize an up-to-date assessment potential antecedents associated with VBD acceptance. A comprehensive search was performed in several reputable databases such Medline (via PubMed), Scopus, Google scholar, Web Science from June 10th, 2023, August 1st, 2023. All relevant descriptive observational studies on hesitancy were included this review. total fifty-eight (58) included, Asia representing highest count thirty-one (53 %) studies, Europe eleven (19 %), United States nine (16 other regions (Africa multi-ethnic) seven (12 %). Worldwide, pooled rate 77.09 % (95 CI: 76.28–78.18), willingness (n) = 164189, sample (N) 212,990. lowest reported American regions, respectively, 85.38 85.02–85.73, 32,047, (N 37,533) vs. 66.92 66.56–67.4), 29335, 43,832. However, multi-ethnic areas moderately high 79.13 78.77–79.23, 93,994, 11,8779) 72.16 71.13–72.93, 9276, 12,853), respectively. most common key across countries "equal safety", "efficacy", "effectiveness", post-vaccination "side effects", "community protection" "family protection", "risk-benefit ratio", necessity", "trust, "variants control". Disparities uptake observed globally, rates found Europe, regions. Multiple including safety, efficacy, side effects hesitancy.

Язык: Английский

Процитировано

5

From Archipelago to Pandemic Battleground: Unveiling Indonesia’s COVID-19 Crisis DOI Creative Commons
Biyan Nathanael Harapan, Triswan Harapan,

Lenny Theodora

и другие.

Journal of Epidemiology and Global Health, Год журнала: 2023, Номер 13(4), С. 591 - 603

Опубликована: Сен. 14, 2023

Abstract The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to countries worldwide, including Indonesia. With its unique archipelagic geography consisting of more than 17,000 thousand islands, Indonesia faces complexities in managing the spread virus. Based on existing literature, this review article elaborates key issues that have shaped Indonesia’s COVID-19 response. begins by examining early stages Indonesia, along with implementation various preventive measures and impact virus public health. This examines how socio-economic factors generally influenced healthcare system further delves into response strategies implemented Indonesian government health authorities as well overall crisis preparedness. It discusses actions taken control virus, testing vaccination efforts. difficulties encountered implementing these are presented. In conclusion, provides a comprehensive understanding covering facts multiple dimensions ranging from timeline efforts, epidemiology, implications, strategies, mobility patterns, holidays, working home, utilization complementary alternative medicine addition standard care for COVID-19. insights gained can complement future management other facing similar challenges.

Язык: Английский

Процитировано

11

Assessing COVID-19 Vaccine Booster Hesitancy Using the Modified 5C Scale in Zhejiang Province, China: A Cross-Sectional Study DOI Creative Commons
Xuan Deng, Yuchen Zhao, Shenyu Wang

и другие.

Vaccines, Год журнала: 2023, Номер 11(3), С. 706 - 706

Опубликована: Март 21, 2023

Following the rollout of a booster campaign to promote immunity against COVID-19 in China, this study aimed assess hesitancy among adults who were fully vaccinated with primary doses across Zhejiang Province. Firstly, modified 5C scale developed by German research team was assessed for reliability and validity via pre-survey Then, 30-item questionnaire established conduct online offline surveys during 10 November 15 December 2021. Demographic characteristics information on previous vaccination experience, vaccine type doses, attitudes towards awareness SARS-CoV-2 infection collected. Chi-square tests, pairwise comparison multivariate logistic regression performed data analysis. In total, 4039 valid questionnaires analyzed, 14.81%. Dissatisfaction experience (ORs = 1.771~8.025), less confidence vaccines (OR 3.511, 95%CI: 2.874~4.310), younger age compared elderly aged 51-60 years old (2.382, 1.274~4.545), lower education level 1.707~2.100), weaker social responsibility prevention control (1.587, 1.353~1.859), inconvenience (1.539, 1.302~1.821), complacency regarding efficacy as well self-health status (1.224, 1.056~1.415) excessive trade-offs before (1.184, 1.005~1.398) positively associated hesitancy. Therefore, intelligent means should be strengthened optimize services. More influential experts other significant figures supported timely evidence-based various media platforms reduce public increase uptake.

Язык: Английский

Процитировано

7

The Role of Knowledge, Attitude, Confidence, and Sociodemographic Factors in COVID-19 Vaccination Adherence among Adolescents in Indonesia: A Nationwide Survey DOI Creative Commons
Defi Efendi,

Sabira Ridha Rifani,

Ariesta Milanti

и другие.

Vaccines, Год журнала: 2022, Номер 10(9), С. 1489 - 1489

Опубликована: Сен. 7, 2022

COVID-19 vaccination in adolescents is important because the adolescent population has highest incidence of COVID-19. This study aimed to explore factors associated with adherence among Indonesian adolescents. cross-sectional involved 7986 adolescents, polled through online and offline surveys conducted six major islands Indonesia. The questionnaire was distributed popular social messaging media platforms. Our team also contacted schools public places recruit participants from remote areas. In total, 7299 respondents completed questionnaire. Binary logistic analysis revealed that higher levels knowledge, positive attitudes, confidence vaccine were significantly Sociodemographic programs. Meanwhile, younger age habitation private housing related lower program. Parental compliance education level, household income, history infection family or friends COVID-19, working status. national authorities stakeholders should take extensive measures increase attitude, confidence, support adolescence multiple channels.

Язык: Английский

Процитировано

12